FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of April, 2005
Commission File Number 001-13896
Elan Corporation, plc
(Translation of registrant's name into English)
Treasury Building, Lower Grand Street, Dublin 2, Ireland
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form 20-F /X/ Form 40-F / /
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1):
Yes / / No /X/
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of
a Form 6-K if submitted solely to provide an attached annual report to security
holders.
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7):
Yes / / No /X/
-2-
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of
a Form 6-K if submitted to furnish a report or other document that the
registrant foreign private issuer must furnish and make public under the laws of
the jurisdiction in which the registrant is incorporated, domiciled or legally
organized (the registrant's "home country"), or under the rules of the home
country exchange on which the registrant's securities are traded, as long as the
report or other document is not a press release, is not required to be and has
not been distributed to the registrant's security holders, and, if discussing a
material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in
this Form, the registrant is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes / / No /X/
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b):
This Report of Foreign Issuer on Form 6-K is incorporated by reference into the
Post-Effective Amendments on Forms F-3 and S-8 to Form F-4 Registration
Statement of Elan Corporation, plc (Registration No. 333-12756), the
Registration Statement on Form F-3 of Elan Corporation, plc and Athena
Neuroscience Finance, LLC (Registration No. 333-13130), and the Registration
Statements on Form S-8 of Elan Corporation, plc (Registration Nos. 333-13996,
333-12344, 333-11940, 333-09644, 333-09284, 333-09048, 333-08384, 333-07361,
333-07136, 333-14240, 33-27506 and 333-100252).
EXHIBIT LIST
Exhibit Description
99.1 Press release dated April 11, 2005 titled:
Elan sets date of April 28 for first quarter 2005 financial
results, and May 26 for the Annual General Meeting. Elan announces
filing of 2004 Form 20-F with SEC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
ELAN CORPORATION, plc
By: /s/ William F. Daniel
--------------------------
William F. Daniel
Company Secretary
Date: April 11, 2005
Exhibit 99.1
FOR IMMEDIATE RELEASE
Investors: Media:
Emer Reynolds Anita Kawatra
Ph: 353-1-709-4000 Ph: 212-407-5740
800-252-3526 Elizabeth Headon
Ph: 353-1-498-0300
ELAN SETS DATE OF APRIL 28 FOR FIRST QUARTER 2005 FINANCIAL RESULTS,
AND MAY 26 FOR THE ANNUAL GENERAL
MEETING
Elan Announces Filing of 2004 Form 20-F with SEC
DUBLIN, IRELAND, APRIL 11, 2005--Elan Corporation, plc today announced that it
will report its first quarter 2005 financial results on April 28, 2005, before
U.S. and European financial markets open. The results announcement will be
followed by a conference call at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British
Summer Time (BST) with the investment community to discuss Elan's first quarter
2005 financial results. Live audio of the conference call will be simultaneously
broadcast over the Internet and will be available to investors, members of the
news media and the general public. This event will be webcast live and can be
accessed by going to the Investor Relations section on Elan's website at
www.elan.com.
Elan will hold its Annual General Meeting at 10:00 a.m. BST on May 26, 2005 at
the Westin Hotel, Westmoreland Street, Dublin 2, Ireland. This event will also
be webcast live and can be accessed by going to the Investor Relations section
on Elan's website at www.elan.com.
Elan has filed with the Securities and Exchange Commission its Form 20-F for the
fiscal year ended December 31, 2004 and has published its Annual Report for the
fiscal year ended December 31, 2004. Both these documents are available on the
Investor Relations section of Elan's website at www.elan.com.
About Elan
Elan Corporation, plc is a neuroscience-based biotechnology company that is
focused on discovering, developing, manufacturing and marketing advanced
therapies in neurology, autoimmune diseases, and severe pain. Elan (NYSE: ELN)
shares trade on the New York, London and Dublin Stock Exchanges.